EurekAlert! -
19 May 2014 06:00
(Institut Laue-Langevin) Results from neutron spin-echo analysis at the Institut Laue-Langevin and the National Center of Neutron Research in the United States are an important advance towards enabling subcutaneous injections of concentrated biopharmaceuticals used to treat cancer and autoimmune disorders (e.g. arthritis, multiple sclerosis). The insights obtained could help drug companies reduce the viscosity and mitigate phase separation in injectable biopharmaceuticals, making them easier to ...
Share this Article